Strategic communications
for the biotech industry.
Experience
-
Independent Consultant
June 2022 – present
Providing communications and investor relations consulting services to venture firms and drug developers at the forefront of innovation
-
Communications and Investor Relations
February 2019 – present
-
Communications and Investor Relations
Emerging Biotech PracticeJanuary 2017 – February 2019
-
R&D Communications
Supported through acquisition by ShireOctober 2015 – April 2016
-
Communications
Pharma and Digital Health PracticeJanuary 2015 – August 2015
Education
Master of Business Administration
Master of Arts in Health Communication
Bachelor of Science in Business Administration
Concentration in Entrepreneurship
Minor in Biology
Clients Include